Literature DB >> 24222788

Author's reply: Use of discard pleural fluid in molecular research.

Erin M Olson1, Nancy U Lin, Ian E Krop, Eric P Winer.   

Abstract

Entities:  

Year:  2012        PMID： 24222788      PMCID： PMC3821068          DOI： 10.1038/nrclinonc.2011.114-c2

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  8 in total

1.  Use of discard pleural fluid in molecular research.

Authors:  Frederic W Grannis
Journal:  Nat Rev Clin Oncol       Date:  2011-12-13       Impact factor: 66.675

Review 2.  Pneumothorax following thoracentesis: a systematic review and meta-analysis.

Authors:  Craig E Gordon; David Feller-Kopman; Ethan M Balk; Gerald W Smetana
Journal:  Arch Intern Med       Date:  2010-02-22

Review 3.  Diagnostic molecular biomarkers for malignant pleural effusions.

Authors:  Krishna B Sriram; Vandana Relan; Belinda E Clarke; Edwina E Duhig; Ian A Yang; Rayleen V Bowman; Y C Gary Lee; Kwun M Fong
Journal:  Future Oncol       Date:  2011-06       Impact factor: 3.404

Review 4.  The ethical use of mandatory research biopsies.

Authors:  Erin M Olson; Nancy U Lin; Ian E Krop; Eric P Winer
Journal:  Nat Rev Clin Oncol       Date:  2011-08-02       Impact factor: 66.675

5.  Identification of tissue of origin in body fluid specimens using a gene expression microarray assay.

Authors:  Gregory A Stancel; Donna Coffey; Karla Alvarez; Meredith Halks-Miller; Anita Lal; Dina Mody; Tracy Koen; Todd Fairley; Federico A Monzon
Journal:  Cancer Cytopathol       Date:  2011-06-29       Impact factor: 5.284

6.  Usefulness of EGFR mutation screening in pleural fluid to predict the clinical outcome of gefitinib treated patients with lung cancer.

Authors:  Junichi Soh; Shinichi Toyooka; Keisuke Aoe; Hiroaki Asano; Syuji Ichihara; Hideki Katayama; Akio Hiraki; Katsuyuki Kiura; Motoi Aoe; Yoshifumi Sano; Kazuro Sugi; Nobuyoshi Shimizu; Hiroshi Date
Journal:  Int J Cancer       Date:  2006-11-15       Impact factor: 7.396

7.  EGFR mutation status in pleural fluid predicts tumor responsiveness and resistance to gefitinib.

Authors:  Junichi Soh; Shinichi Toyooka; Shuji Ichihara; Hiroshi Suehisa; Naruyuki Kobayashi; Sachio Ito; Masaomi Yamane; Motoi Aoe; Yoshifumi Sano; Katsuyuki Kiura; Hiroshi Date
Journal:  Lung Cancer       Date:  2007-03-01       Impact factor: 5.705

8.  Diagnostic utility of LunX mRNA in peripheral blood and pleural fluid in patients with primary non-small cell lung cancer.

Authors:  Min Cheng; Yongyan Chen; Xiaoqing Yu; Zhigang Tian; Haiming Wei
Journal:  BMC Cancer       Date:  2008-05-31       Impact factor: 4.430
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.